Ignite Creation Date:
2024-05-06 @ 3:21 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04609293
Status:
UNKNOWN
Last Update Posted:
2020-10-30
First Post:
2020-10-26
Brief Title:
Observational Study of Camrelizumab Combined With Apatinib and Hyperfractionated Radiotherapy for Renal Cell Carcinoma
Sponsor:
Peking University First Hospital
Organization:
Peking University First Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Renal Cell Carcinoma |
Keywords: